With the allocation of 50 per cent of funds towards the JV and the rest towards Acculi’s diverse offerings, the company is striving to enhance its manpower, operational efficiency, infrastructure development, and manufacturing and production capacity
Read More
EvolutionaryScale plans to utilise the new funding to train its next generation of AI models and expand its team to collaborate with the biotech industry
Read More
